368 related articles for article (PubMed ID: 31326236)
1. Insights into Computational Drug Repurposing for Neurodegenerative Disease.
Paranjpe MD; Taubes A; Sirota M
Trends Pharmacol Sci; 2019 Aug; 40(8):565-576. PubMed ID: 31326236
[TBL] [Abstract][Full Text] [Related]
2. Application of artificial intelligence and machine learning in drug repurposing.
Ghandikota SK; Jegga AG
Prog Mol Biol Transl Sci; 2024; 205():171-211. PubMed ID: 38789178
[TBL] [Abstract][Full Text] [Related]
3. Machine and deep learning approaches for cancer drug repurposing.
Issa NT; Stathias V; Schürer S; Dakshanamurthy S
Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence, machine learning, and drug repurposing in cancer.
Tanoli Z; Vähä-Koskela M; Aittokallio T
Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
[No Abstract] [Full Text] [Related]
5. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
6. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
[TBL] [Abstract][Full Text] [Related]
7. D
Savva K; Zachariou M; Bourdakou MM; Dietis N; Spyrou GM
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791356
[TBL] [Abstract][Full Text] [Related]
8. An Analytical Review of Computational Drug Repurposing.
Sadeghi SS; Keyvanpour MR
IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):472-488. PubMed ID: 31403439
[TBL] [Abstract][Full Text] [Related]
9. Drug repurposing in silico screening platforms.
Mullins JGL
Biochem Soc Trans; 2022 Apr; 50(2):747-758. PubMed ID: 35285479
[TBL] [Abstract][Full Text] [Related]
10. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
Karatzas E; Kolios G; Spyrou GM
Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
[TBL] [Abstract][Full Text] [Related]
11. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.
Cummings JL; Zhong K
Expert Rev Clin Pharmacol; 2014 Mar; 7(2):161-5. PubMed ID: 24502586
[TBL] [Abstract][Full Text] [Related]
12. Synergizing drug repurposing and target identification for neurodegenerative diseases.
Sahu M; Vashishth S; Kukreti N; Gulia A; Russell A; Ambasta RK; Kumar P
Prog Mol Biol Transl Sci; 2024; 205():111-169. PubMed ID: 38789177
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
Lanza V; Milardi D; Di Natale G; Pappalardo G
Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
[TBL] [Abstract][Full Text] [Related]
14. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
Kashyap K; Siddiqi MI
Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
[TBL] [Abstract][Full Text] [Related]
15. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.
Jain P; Jain SK; Jain M
Curr Mol Med; 2021; 21(2):111-132. PubMed ID: 32560606
[TBL] [Abstract][Full Text] [Related]
16. Advancements in Drug Repurposing: Examples in Psychiatric Medications.
Okuyama R
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446178
[TBL] [Abstract][Full Text] [Related]
17. Drug Repurposing for Cancer Therapy in the Era of Precision Medicine.
K W To K; Cho WCS
Curr Mol Pharmacol; 2022; 15(7):895-903. PubMed ID: 35156588
[TBL] [Abstract][Full Text] [Related]
18. Application of Artificial Intelligence in COVID-19 drug repurposing.
Mohanty S; Harun Ai Rashid M; Mridul M; Mohanty C; Swayamsiddha S
Diabetes Metab Syndr; 2020; 14(5):1027-1031. PubMed ID: 32634717
[TBL] [Abstract][Full Text] [Related]
19. Drug Repositioning Strategies for the Identification of Novel Therapies for Rheumatic Autoimmune Inflammatory Diseases.
Grammer AC; Lipsky PE
Rheum Dis Clin North Am; 2017 Aug; 43(3):467-480. PubMed ID: 28711146
[TBL] [Abstract][Full Text] [Related]
20. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.
Nowak-Sliwinska P; Scapozza L; Ruiz i Altaba A
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):434-454. PubMed ID: 31034926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
